IP Verse

Aragon Pharmaceuticals competitive analysis

Latest publications and patents of Aragon Pharmaceuticals New

Explore the latest publications and patents granted to Aragon Pharmaceuticals, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Aragon Pharmaceuticals

EP3226841
Oct 9, 2024Anticancer CompositionsGranted And Under Opposition
EP3226843
May 26, 2021Anticancer CompositionsGranted And Under Opposition
EP3533792
May 5, 2021Crystalline Forms Of An Androgen Receptor ModulatorOpposition Rejected
EP3226842
Nov 25, 2020Anticancer CompositionsGranted And Under Opposition
EP3305285
Sep 2, 2020Anti-Androgens For The Treatment Of Non-Metastatic Castrate-Resistant Prostate CancerRevoked
EP3348553
Jul 8, 2020Crystalline Forms Of An Androgen Receptor ModulatorRevoked
EP2945628
Apr 15, 2020Androgen Receptor Modulator And Uses ThereofRevoked
EP2858985
Apr 18, 2018Crystalline Forms Of An Androgen Receptor ModulatorOpposition Rejected

Latest patents of Aragon Pharmaceuticals opposed by its competitors

Explore Aragon Pharmaceuticals's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
EP3226841
Oct 9, 2024Anticancer Compositions6
EP3226843
May 26, 2021Anticancer Compositions1
EP3533792
May 5, 2021Crystalline Forms Of An Androgen Receptor Modulator1
EP3226842
Nov 25, 2020Anticancer Compositions2
EP3305285
Sep 2, 2020Anti-Androgens For The Treatment Of Non-Metastatic Castrate-Resistant Prostate Cancer3
EP3348553
Jul 8, 2020Crystalline Forms Of An Androgen Receptor Modulator2
EP2945628
Apr 15, 2020Androgen Receptor Modulator And Uses Thereof4
EP2858985
Apr 18, 2018Crystalline Forms Of An Androgen Receptor Modulator3

Latest PTAB cases involving Aragon Pharmaceuticals

Discover the latest PTAB cases involving Aragon Pharmaceuticals, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Aragon Pharmaceuticals with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ARAGON PHARMACEUTICALS - 22 - - Non-Active
GENERICS UK211 - - - Highly Aggressive
SANDOZ1141519 - Highly Aggressive
TEVA PHARMACEUTICALS20515 - 12Highly Aggressive